Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voice-preserving Treatment of Laryngeal Papilloma
NCT00592319Phase 2Terminated
- Sponsor
- Boston University
- Start
- May 2005
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of celecoxib oral solution in laryngeal papillomatosis (RRP) (2 arms), sponsored by Boston University. Primary endpoint: Number of Case With Papilloma Recurrence During a 12-month Follow up. Started May 2005; status: terminated.
02
Drugs
celecoxib oral solution
03
Conditions
laryngeal papillomatosis (RRP)
Beyond the preview
Go deeper on NCT00592319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00592319.